Imugene Ltd
ASX:IMU

Watchlist Manager
Imugene Ltd Logo
Imugene Ltd
ASX:IMU
Watchlist
Price: 0.4 AUD Market Closed
Market Cap: 87.8m AUD

Relative Value

There is not enough data to reliably calculate the relative value of IMU.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

IMU Relative Value
Base Case
Not Available
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
7.3
vs History
vs Industry
Median 3Y
-9.6
Median 5Y
-22.2
Industry
23.3
Forward
-0.6
vs History
vs Industry
Median 3Y
-20.1
Median 5Y
-22.9
Industry
19.8
vs History
vs Industry
Median 3Y
-19.1
Median 5Y
-21.8
Industry
22.6
vs History
98
vs Industry
24
Median 3Y
3.9
Median 5Y
4.4
Industry
2.7
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
7.6
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
9.4
vs History
vs Industry
Median 3Y
-7
Median 5Y
-18.2
Industry
4.7
Forward
-0.5
vs History
vs Industry
Median 3Y
-7
Median 5Y
-18.2
Industry
4.8
Forward
-0.5
vs History
vs Industry
Median 3Y
-15.6
Median 5Y
-20
Industry
5.3
vs History
vs Industry
Median 3Y
-15.6
Median 5Y
-18.5
Industry
3.8
vs History
98
vs Industry
39
Median 3Y
7.5
Median 5Y
13.3
Industry
5

Multiples Across Competitors

IMU Competitors Multiples
Imugene Ltd Competitors

Market Cap P/S P/E EV/EBITDA EV/EBIT
AU
Imugene Ltd
ASX:IMU
87.8m AUD 0 -0.7 -0.4 -0.4
FR
Pharnext SCA
OTC:PNEXF
6T USD 33 841 650.5 -160 844.3 -195 316.3 -193 087.6
US
Abbvie Inc
NYSE:ABBV
344.4B USD 6 82.9 15.7 23.2
US
Amgen Inc
NASDAQ:AMGN
161.3B USD 4.7 27.2 14.6 24
US
Gilead Sciences Inc
NASDAQ:GILD
142.6B USD 5 23.9 10.4 14.3
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
123.5B USD 11.1 -124.8 26.6 27.9
US
Epizyme Inc
F:EPE
94.1B EUR 2 081.7 -531.2 -578.4 -563
AU
CSL Ltd
ASX:CSL
117.4B AUD 5 27.9 17.2 21.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
60.6B USD 4.3 13.5 12 13.5
US
Seagen Inc
F:SGT
39.3B EUR 20.1 -61.5 -66.3 -59.8
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
42B USD 17.9 -155.8 -699.1 -350.3
P/S Multiple
Revenue Growth P/S to Growth
AU
Imugene Ltd
ASX:IMU
Average P/S: 3 384 380.6
Not Available
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
33 841 650.5
N/A N/A
US
Abbvie Inc
NYSE:ABBV
6
8%
0.8
US
Amgen Inc
NASDAQ:AMGN
4.7
4%
1.2
US
Gilead Sciences Inc
NASDAQ:GILD
5
3%
1.7
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
11.1
10%
1.1
US
E
Epizyme Inc
F:EPE
2 081.7
N/A N/A
AU
CSL Ltd
ASX:CSL
5
7%
0.7
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
4.3
4%
1.1
US
S
Seagen Inc
F:SGT
20.1
30%
0.7
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
17.9
29%
0.6
P/E Multiple
Earnings Growth PEG
AU
Imugene Ltd
ASX:IMU
Average P/E: 35.1
Negative Multiple: -0.7
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -160 844.3 N/A N/A
US
Abbvie Inc
NYSE:ABBV
82.9
88%
0.9
US
Amgen Inc
NASDAQ:AMGN
27.2
45%
0.6
US
Gilead Sciences Inc
NASDAQ:GILD
23.9
188%
0.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -124.8 N/A N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -531.2 N/A N/A
AU
CSL Ltd
ASX:CSL
27.9
16%
1.7
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
13.5
7%
1.9
US
S
Seagen Inc
F:SGT
Negative Multiple: -61.5 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -155.8 N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
AU
Imugene Ltd
ASX:IMU
Average EV/EBITDA: 16.1
Negative Multiple: -0.4
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -195 316.3 N/A N/A
US
Abbvie Inc
NYSE:ABBV
15.7
13%
1.2
US
Amgen Inc
NASDAQ:AMGN
14.6
17%
0.9
US
Gilead Sciences Inc
NASDAQ:GILD
10.4
6%
1.7
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
26.6
17%
1.6
US
E
Epizyme Inc
F:EPE
Negative Multiple: -578.4 N/A N/A
AU
CSL Ltd
ASX:CSL
17.2
11%
1.6
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
12
11%
1.1
US
S
Seagen Inc
F:SGT
Negative Multiple: -66.3 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -699.1 N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
AU
Imugene Ltd
ASX:IMU
Average EV/EBIT: 20.7
Negative Multiple: -0.4
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -193 087.6 N/A N/A
US
Abbvie Inc
NYSE:ABBV
23.2
29%
0.8
US
Amgen Inc
NASDAQ:AMGN
24
32%
0.7
US
Gilead Sciences Inc
NASDAQ:GILD
14.3
11%
1.3
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
27.9
17%
1.6
US
E
Epizyme Inc
F:EPE
Negative Multiple: -563 N/A N/A
AU
CSL Ltd
ASX:CSL
21.5
14%
1.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
13.5
11%
1.2
US
S
Seagen Inc
F:SGT
Negative Multiple: -59.8 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -350.3 N/A N/A